AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
-3.65%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$3.36B
AUM Growth
+$3.36B
(-16%)
Cap. Flow
-$256M
Cap. Flow
% of AUM
-7.6%
Top 10 Holdings %
Top 10 Hldgs %
27.79%
Holding
302
New
82
Increased
55
Reduced
75
Closed
50
Top Buys
| 1 |
PTC Therapeutics
PTCT
|
$65.3M |
| 2 |
Immunovant
IMVT
|
$39.8M |
| 3 |
AB InBev
BUD
|
$38.9M |
| 4 |
Ironwood Pharmaceuticals
IRWD
|
$33.3M |
| 5 |
Charles River Laboratories
CRL
|
$30.6M |
Top Sells
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$114M |
| 2 |
Pfizer
PFE
|
$76.9M |
| 3 |
Johnson & Johnson
JNJ
|
$50.7M |
| 4 |
Neurocrine Biosciences
NBIX
|
$48.8M |
| 5 |
Incyte
INCY
|
$42.7M |
Sector Composition
| 1 | Healthcare | 66.93% |
| 2 | Consumer Staples | 12.81% |
| 3 | Technology | 8.13% |
| 4 | Consumer Discretionary | 7.55% |
| 5 | Communication Services | 3.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Kraft Heinz
KHC
$33.1B
| $43.4M | 0.67% | 1,291,008 +441,008 | +52% | +$14.8M |
|
27
Microsoft
MSFT
$3.77T
| $42.2M | 0.65% | 133,499 -26,501 | -17% | -$8.37M |
|
28
Jazz Pharmaceuticals
JAZZ
$7.75B
| $40.5M | 0.62% | 312,744 -143,256 | -31% | -$18.5M |
|
29
Vertex Pharmaceuticals
VRTX
$100B
| $40.4M | 0.62% | 116,117 -7,883 | -6% | -$2.74M |
|
|
30
Immunovant
IMVT
$2.56B
| $39.8M | 0.61% | +1,035,877 | New | +$39.8M |
|
31
Novo Nordisk
NVO
$251B
| $39.6M | 0.61% | 436,000 +166,000 | +61% | +$15.1M |
|
|
PARA
32
DELISTED
Paramount Global Class B
PARA
| $39.6M | 0.61% | 3,071,559 +283,559 | +10% | +$3.66M |
|
|
33
AB InBev
BUD
$122B
| $38.9M | 0.6% | +703,000 | New | +$38.9M |
|
34
Orthofix Medical
OFIX
$592M
| $38.1M | 0.58% | 2,964,000 +528,000 | +22% | +$6.79M |
|
|
35
Ironwood Pharmaceuticals
IRWD
$214M
| $33.3M | 0.51% | +3,456,000 | New | +$33.3M |
|
36
Voyager Therapeutics
VYGR
$186M
| $32.4M | 0.5% | 4,178,000 +554,000 | +15% | +$4.29M |
|
37
Campbell Soup
CPB
$9.52B
| $32M | 0.49% | 778,571 -1,429 | -0.2% | -$58.7K |
|
|
SWAV
38
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $31.7M | 0.48% | 159,002 +9,002 | +6% | +$1.79M |
|
39
Bristol-Myers Squibb
BMY
$96B
| $30.7M | 0.47% | 529,613 +129,613 | +32% | +$7.52M |
|
|
40
Charles River Laboratories
CRL
$8.04B
| $30.6M | 0.47% | +156,000 | New | +$30.6M |
|
41
Xencor
XNCR
$580M
| $29.8M | 0.46% | 1,478,000 +586,000 | +66% | +$11.8M |
|
42
DocuSign
DOCU
$15.5B
| $29.5M | 0.45% | 703,147 +111,147 | +19% | +$4.67M |
|
43
SentinelOne
S
$6.29B
| $28.5M | 0.44% | 1,692,497 -403,503 | -19% | -$6.8M |
|
44
Intuitive Surgical
ISRG
$170B
| $28.4M | 0.44% | 97,212 +15,212 | +19% | +$4.45M |
|
45
CRISPR Therapeutics
CRSP
$4.71B
| $27.2M | 0.42% | 600,012 +100,012 | +20% | +$4.54M |
|
|
EVBG
46
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $26.1M | 0.4% | 1,164,000 -36,000 | -3% | -$807K |
|
47
Enanta Pharmaceuticals
ENTA
$180M
| $23.5M | 0.36% | 2,100,000 +64,000 | +3% | +$715K |
|
48
Toast
TOST
$26.3B
| $23.2M | 0.36% | 1,237,359 +273,359 | +28% | +$5.12M |
|
49
MacroGenics
MGNX
$112M
| $22M | 0.34% | 4,712,000 -888,000 | -16% | -$4.14M |
|
|
50
Johnson & Johnson
JNJ
$427B
| $20.9M | 0.32% | 134,378 -325,622 | -71% | -$50.7M |
|